Status:

COMPLETED

Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings

Lead Sponsor:

University of Minnesota

Collaborating Sponsors:

Hill-Rom

Conditions:

Cystic Fibrosis

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Our primary hypothesis is that airway clearance therapy with sine waveform HFCWO using higher inflation pressures combined with both low and high oscillator frequencies will result in greater sputum p...

Detailed Description

Patients with cystic fibrosis (CF) perform daily airway clearance therapy to facilitate removal of secretions from their airways. Many different techniques are available to achieve this and there is c...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Diagnosis of CF established by sweat chloride \> 60 mmol/L.
  • Age older than 18 years.
  • History of chronic daily sputum production.
  • Currently on a home therapeutic regimen that includes some form of airway clearance performed with a HFCWO device at least once daily that also includes concomitant use of an inhaled mucolytic and inhaled bronchodilator.
  • FVC and FEV1 \> 40%-predicted, and with stable lung function (no greater than a 10% variation in lung function parameters over the preceding 3 months).
  • Evaluated at the University of Minnesota CF Center 3 or more times in the preceding 12 months.
  • Exclusion criteria:
  • Hospitalization for CF pulmonary complications in the 2 months preceding enrollment.
  • Hemoptysis \> 60 cc in a single episode in the 4 weeks preceding enrollment.
  • Chest pain requiring use of narcotic for pain control.
  • Current participation in another clinical trial.
  • Use of intravenous antibiotics for CF respiratory complications in the 2 months preceding enrollment.
  • No prior experience using HFCWO devices for airway clearance

Exclusion

    Key Trial Info

    Start Date :

    May 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2008

    Estimated Enrollment :

    17 Patients enrolled

    Trial Details

    Trial ID

    NCT00685035

    Start Date

    May 1 2008

    End Date

    October 1 2008

    Last Update

    July 25 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Minnesota Medical Center

    Minneapolis, Minnesota, United States, 55455